Thus, the attenuated inhibition of parasympathetic activity observed in overweight and insulin-resistant individuals during hypoglycaemia may potentially enhance the defence against hypoglycaemia and the maintenance of elevated everyday glucose levels. The gene discussed is INS; the disease is Hypoglycemia.